Complex regional pain syndrome type 2 (CRPS2), or causalgia is a form of complex regional pain syndrome that develops after damage to a peripheral nerve and is characterized by spontaneous pain, allod...
Comprehensive, easy-to-understand information about this condition
How we create this content →The limited documentation surrounding complex regional pain syndrome type 2 is primarily due to its rarity and the complexity of its symptoms, which can overlap with other pain disorders. As CRPS2 affects fewer individuals, comprehensive clinical studies are scarce, and the absence of identified genetic factors further complicates the understanding of this condition. This can understandably lead to frustration for those affected, but ongoing research holds promise for better characterization and treatment options.
To navigate your care for complex regional pain syndrome type 2, consider consulting a pain specialist or a neurologist with experience in neuropathic pain conditions. These professionals can provide targeted management strategies. Additionally, organizations like the National Organization for Rare Disorders (NORD) offer resources and support for individuals with rare diseases; you can visit their website at rarediseases.org for more information. Participating in clinical trials may also provide access to new therapies and contribute to valuable research. Keep an eye on ongoing studies related to CRPS2 for potential opportunities.
Currently, there are several orphan drugs designated for CRPS2, including afatinib, baclofen, and ketamine, among others. These drugs are in various stages of development, indicating a growing interest in finding effective treatments. Additionally, there are two active clinical trials exploring potential therapies for this condition. For more information on these trials, you can visit ClinicalTrials.gov and search for 'complex regional pain syndrome type 2'. This research landscape offers hope for improved management strategies in the future.
Actionable guidance for navigating care for complex regional pain syndrome type 2
To navigate your care for complex regional pain syndrome type 2, consider consulting a pain specialist or a neurologist with experience in neuropathic pain conditions. These professionals can provide targeted management strategies. Additionally, organizations like the National Organization for Rare Disorders (NORD) offer resources and support for individuals with rare diseases; you can visit their website at rarediseases.org for more information. Participating in clinical trials may also provide access to new therapies and contribute to valuable research. Keep an eye on ongoing studies related to CRPS2 for potential opportunities.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding complex regional pain syndrome type 2 is primarily due to its rarity and the complexity of its symptoms, which can overlap with other pain disorders. As CRPS2 affects fewer individuals, comprehensive clinical studies are scarce, and the absence of identified genetic factors further complicates the understanding of this condition. This can understandably lead to frustration for those affected, but ongoing research holds promise for better characterization and treatment options.
To navigate your care for complex regional pain syndrome type 2, consider consulting a pain specialist or a neurologist with experience in neuropathic pain conditions. These professionals can provide targeted management strategies. Additionally, organizations like the National Organization for Rare Disorders (NORD) offer resources and support for individuals with rare diseases; you can visit their website at rarediseases.org for more information. Participating in clinical trials may also provide access to new therapies and contribute to valuable research. Keep an eye on ongoing studies related to CRPS2 for potential opportunities.
Currently, there are several orphan drugs designated for CRPS2, including afatinib, baclofen, and ketamine, among others. These drugs are in various stages of development, indicating a growing interest in finding effective treatments. Additionally, there are two active clinical trials exploring potential therapies for this condition. For more information on these trials, you can visit ClinicalTrials.gov and search for 'complex regional pain syndrome type 2'. This research landscape offers hope for improved management strategies in the future.
Actionable guidance for navigating care for complex regional pain syndrome type 2
To navigate your care for complex regional pain syndrome type 2, consider consulting a pain specialist or a neurologist with experience in neuropathic pain conditions. These professionals can provide targeted management strategies. Additionally, organizations like the National Organization for Rare Disorders (NORD) offer resources and support for individuals with rare diseases; you can visit their website at rarediseases.org for more information. Participating in clinical trials may also provide access to new therapies and contribute to valuable research. Keep an eye on ongoing studies related to CRPS2 for potential opportunities.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding complex regional pain syndrome type 2 is primarily due to its rarity and the complexity of its symptoms, which can overlap with other pain disorders. As CRPS2 affects fewer individuals, comprehensive clinical studies are scarce, and the absence of identified genetic factors further complicates the understanding of this condition. This can understandably lead to frustration for those affected, but ongoing research holds promise for better characterization and treatment options.
To navigate your care for complex regional pain syndrome type 2, consider consulting a pain specialist or a neurologist with experience in neuropathic pain conditions. These professionals can provide targeted management strategies. Additionally, organizations like the National Organization for Rare Disorders (NORD) offer resources and support for individuals with rare diseases; you can visit their website at rarediseases.org for more information. Participating in clinical trials may also provide access to new therapies and contribute to valuable research. Keep an eye on ongoing studies related to CRPS2 for potential opportunities.
Currently, there are several orphan drugs designated for CRPS2, including afatinib, baclofen, and ketamine, among others. These drugs are in various stages of development, indicating a growing interest in finding effective treatments. Additionally, there are two active clinical trials exploring potential therapies for this condition. For more information on these trials, you can visit ClinicalTrials.gov and search for 'complex regional pain syndrome type 2'. This research landscape offers hope for improved management strategies in the future.
Actionable guidance for navigating care for complex regional pain syndrome type 2
To navigate your care for complex regional pain syndrome type 2, consider consulting a pain specialist or a neurologist with experience in neuropathic pain conditions. These professionals can provide targeted management strategies. Additionally, organizations like the National Organization for Rare Disorders (NORD) offer resources and support for individuals with rare diseases; you can visit their website at rarediseases.org for more information. Participating in clinical trials may also provide access to new therapies and contribute to valuable research. Keep an eye on ongoing studies related to CRPS2 for potential opportunities.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.